idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
07/08/2009 09:56

Estrogen-Dependent Switch Tempers Killing Activity of Immune Cells

Barbara Bachtler Presse- und Öffentlichkeitsarbeit
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch

    The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses. The key player in this process is a cytotoxic T cell molecule which has been known for a long time and which scientists have named EBAG9. Cancer researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité, Germany, have now unraveled the function of EBAG9. Modulated by estrogen, EBAG9 tempers the activity of CTLs. In the absence of EBAG9, the activity of CTLs is enhanced (Journal of Clinical Investigation, Vol. 119, No. 8, pp 2184-2203, August 3, 2009)*.

    The sex hormone estrogen plays a critical role in the regulation of growth and the development of cells. It is also crucial for cell-type-specific gene expression in various tissues. Deregulation of this system results in breast and ovarian cancer.

    Those tumors are successfully treated with drugs such as tamoxifen. Researchers suggest that this drug inhibits tumor growth by blocking the estrogen receptors of the tumor cells. However, up to now it has been unclear what effect this inhibition has on the immune system.

    In a previous study, Japanese researchers detected large amounts of EBAG9 in estrogen-dependent tumors. Dr. Rehm and his colleagues wondered what effect elevated levels of estrogen would have on cytotoxic T cells that attack tumors. They assumed that EBAG9 could transmit this effect of estrogen and therefore wanted to know what would happen if they knocked out the gene for EBAG9 in mice.

    After knocking out the gene for EBAG9, they found that in the absence of EBAG9 the "brake" of the immune cells is loosened. The immune cells can release much more of the tumor-killing enzymes than in the presence of EBAG9. The deathly harbingers are stored in granules (secretory lysosomes) in the cytotoxic T cells. They have greater quantities of these granules at their disposal once the blockage of the immune cells through EBAG9 is lifted.

    These findings of the researchers in Berlin may also explain why drugs like tamoxifen act on tumor cell growth. One argument is that once the estrogen receptors of the tumor cells are inhibited by the drug, the sex hormone can no longer promote tumor growth. At the same time EBAG9 can no longer inhibit the cytotoxic T cells. The immune cells are ready to attack and destroy the tumor cells.

    "In this way, tamoxifen not only inhibits tumor growth but may also be able to enhance the effect of the immune system," Dr. Rehm said. His working hypothesis is that EBAG9 acts as a molecular switch which regulates the immune cells.

    As a next step, he and his colleagues plan to study cytotoxic T cells from patients with estrogen-dependent tumors to see if EBAG9 levels are increased.

    *The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells

    Constantin Rüder,1 Uta E. Höpken,1 Jana Wolf,1 Hans-Willi Mittrücker,2 Boris Engels,1 Bettina Erdmann,1 Susanne Wollenzin,1 Wolfgang Uckert,1 Bernd Dörken,1,3 and Armin Rehm1,3

    1Max Delbrück Center for Molecular Medicine, Berlin, Germany.
    2Institute for Immunology, University Medical Center, Hamburg-Eppendorf, Germany.
    3Universitätsmedizin Berlin, Charité, Virchow Clinics, Berlin, Germany.


    Barbara Bachtler
    Press and Public Affairs
    Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
    Robert-Rössle-Straße 10; 13125 Berlin; Germany
    Phone: +49 (0) 30 94 06 - 38 96
    Fax: +49 (0) 30 94 06 - 38 33
    e-mail: presse@mdc-berlin.de
    http://www.mdc-berlin.de/


    More information:

    http://Further Information:
    http://www.jci.org/articles/view/37760/pdf
    http://www.jci.org/articles/view/40270/pdf


    Images

    Criteria of this press release:
    Biology, Chemistry, Medicine
    transregional, national
    Research results
    English


     

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).